REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 204 filers reported holding REPLIGEN CORP in Q3 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,915,254 | +57.0% | 106,379 | +39.7% | 0.01% | +60.0% |
Q2 2023 | $10,770,798 | +30.2% | 76,140 | -80.0% | 0.01% | +25.0% |
Q1 2023 | $8,273,188 | -53.0% | 381,134 | +267.0% | 0.00% | -55.6% |
Q4 2022 | $17,584,986 | -10.2% | 103,863 | -0.7% | 0.01% | -18.2% |
Q3 2022 | $19,575,000 | +14.5% | 104,617 | -0.6% | 0.01% | +10.0% |
Q2 2022 | $17,091,000 | -20.7% | 105,240 | -8.2% | 0.01% | -9.1% |
Q1 2022 | $21,560,000 | -23.6% | 114,628 | +7.6% | 0.01% | -21.4% |
Q4 2021 | $28,207,000 | -5.1% | 106,506 | +3.6% | 0.01% | -12.5% |
Q3 2021 | $29,716,000 | +306.7% | 102,827 | +180.9% | 0.02% | +300.0% |
Q2 2021 | $7,307,000 | +20.1% | 36,606 | +16.9% | 0.00% | 0.0% |
Q1 2021 | $6,086,000 | +14.1% | 31,304 | +12.5% | 0.00% | 0.0% |
Q4 2020 | $5,332,000 | +39.7% | 27,823 | +7.6% | 0.00% | +33.3% |
Q3 2020 | $3,817,000 | +36.6% | 25,869 | +14.4% | 0.00% | 0.0% |
Q2 2020 | $2,795,000 | +51.2% | 22,615 | +18.1% | 0.00% | +50.0% |
Q1 2020 | $1,849,000 | -2.9% | 19,150 | -7.0% | 0.00% | 0.0% |
Q4 2019 | $1,904,000 | +21.9% | 20,589 | +1.1% | 0.00% | 0.0% |
Q3 2019 | $1,562,000 | -11.8% | 20,364 | -1.2% | 0.00% | 0.0% |
Q2 2019 | $1,771,000 | +43.3% | 20,609 | -1.5% | 0.00% | 0.0% |
Q1 2019 | $1,236,000 | +254.2% | 20,914 | +216.0% | 0.00% | +100.0% |
Q4 2018 | $349,000 | -7.4% | 6,619 | -17.5% | 0.00% | 0.0% |
Q2 2018 | $377,000 | +69.8% | 8,021 | +30.8% | 0.00% | 0.0% |
Q1 2018 | $222,000 | +19.4% | 6,130 | +19.5% | 0.00% | – |
Q4 2017 | $186,000 | -20.2% | 5,128 | -15.6% | 0.00% | -100.0% |
Q3 2017 | $233,000 | -23.1% | 6,078 | -17.0% | 0.00% | 0.0% |
Q2 2017 | $303,000 | +21.7% | 7,321 | +3.4% | 0.00% | 0.0% |
Q1 2017 | $249,000 | +26.4% | 7,082 | +10.9% | 0.00% | 0.0% |
Q4 2016 | $197,000 | +5.9% | 6,388 | +3.6% | 0.00% | 0.0% |
Q3 2016 | $186,000 | +23.2% | 6,165 | +11.4% | 0.00% | 0.0% |
Q2 2016 | $151,000 | +2.0% | 5,536 | +0.2% | 0.00% | 0.0% |
Q1 2016 | $148,000 | +66.3% | 5,527 | +75.5% | 0.00% | – |
Q4 2015 | $89,000 | +89.4% | 3,150 | +87.4% | 0.00% | – |
Q3 2015 | $47,000 | – | 1,681 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |